Piush Mandhane, MD, PhD, FRCPC
Professor, Department of Pediatrics, Division of Pediatric Respirology, Pulmonary and Asthma, University of Alberta

Dr. Piush Mandhane is a Paediatric Respirologist Clinician Scientist at the University of Alberta and Stollery Children’s Hospital. His work through the CHILD birth cohort centered on childhood sleep and neurodevelopment. Through the pandemic, Dr. Mandhane examined childhood immunity to SARS-CoV-2 infection. More recently, he has focused on paediatric long COVID as a principal investigator of the recently-funded long COVID web and co-chairing a Alberta Health Services committee developing care pathways for paediatric long COVID.

Matthew Bromwich, MD, FRCSC
Department of Pediatric Otolaryngology, CHEO, Director TECHi, CHEO, Investigator, CHEO Research Institute, Associate Professor of Otolaryngology, University of Ottawa

Dr. Matthew Bromwich is a leading Otolaryngologist and Associate Professor at the University of Ottawa. He is the director of TECHi at the CHEO-RI, whose main objective is advancing healthcare innovation by partnering with early stage companies to elevate the healthcare industry. His own ground-breaking work includes the creation of the “Shoebox Audiometer,” a portable, user-friendly hearing assessment device that revolutionizes access to care. Dr. Bromwich’s ongoing research and innovations continue to positively impact patients worldwide.

Christine Bear, PhD
Senior Scientist, Molecular Medicine, SickKids

Christine Bear is a Senior Scientist at SickKids Hospital and Professor at the University of Toronto. She co-directs the Cystic Fibrosis research program that makes mini-lungs from patient stem cells and uses these mini-lungs to find out which drugs are best for each person. With continuing support, Dr. Bear will use the program to optimize the efficacy and safety of tools that aim to prevent CF in children by removing CF mutations through genome editing.

Vijay Ramaswamy, MD, PhD, FRCPC
Canada Research Chair in Pediatric Neuro-Oncology, Scientist and Staff Neuro-Oncologist, Hospital for Sick Children, Associate Professor, University of Toronto

Dr. Vijay Ramaswamy is currently appointed as both a Scientist and Pediatric Neuro-Oncologist at the Hospital for Sick Children. He is a cancer biologist with an interest in the genomics of pediatric brain tumours, specifically defining high-risk subsets and investigating novel therapeutic strategies to overcome treatment resistance. With ongoing support from the Canadian Institutes for Health Research, Canadian Cancer Society and Brain Canada, he is using functional genomics to advance our understanding of treatment failure.

Quynh Doan, MDCM, FRCPC, MHSc, PhD
Investigator and Pediatric Emergency Physician, BC Children’s Hospital, Provincial Health Services Authority (PHSA) and Associate Professor, Pediatric Emergency Medicine, Department of Pediatrics, University of British Columbia

Dr.Quynh Doan is a pediatric emergency physician and health services researcher at the University of British Columbia. She is also the Interim Senior Executive Director and Director of Clinical Research at the BC Children’s Hospital Research Institute, where she fosters thought diversity and inclusive experiences. Her research and institutional practices aim to optimize inclusivity and minimize participants exclusion based on language proficiency, for generalizable knowledge creation, enabling equitable and evidence based child health.

Stacey Marjerrison, MD, MSc, FRCPC
Pediatric Oncologist and Medical Director of Pediatric Oncology Late Effects Program, McMaster University

Dr. Stacey Marjerrison is a pediatric oncologist and Medical Director of the AfterCare Program at McMaster Children’s Hospital. She is an Associate Professor at McMaster University where she holds the Ronald Barr Professorship in Pediatric Oncology. Within the Canadian Pediatric Cancer Consortium, Dr. Marjerrison leads the Social justice, Indigenization and Inclusion working group. Her areas of research interest are cancer survivorship, supportive care, and the interaction between socio-demographic determinants of health and childhood chronic illness.